Systems Pharmacology-Based Precision Therapy and Drug Combination Discovery for Breast Cancer
Breast cancer (BC) is a common disease and one of the main causes of death in females worldwide. In the omics era, researchers have used various high-throughput sequencing technologies to accumulate massive amounts of biomedical data and reveal an increasing number of disease-related mutations/genes...
Main Authors: | Ze-Jia Cui, Min Gao, Yuan Quan, Bo-Min Lv, Xin-Yu Tong, Teng-Fei Dai, Xiong-Hui Zhou, Hong-Yu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/14/3586 |
Similar Items
-
PheWAS-Based Systems Genetics Methods for Anti-Breast Cancer Drug Discovery
by: Min Gao, et al.
Published: (2019-02-01) -
Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients
by: Yingqi Xu, et al.
Published: (2019-08-01) -
Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling
by: Robert F. Gruener, et al.
Published: (2021-02-01) -
Systems Pharmacology in Small Molecular Drug Discovery
by: Wei Zhou, et al.
Published: (2016-02-01) -
Integration of Molecular Docking and In Vitro Studies: A Powerful Approach for Drug Discovery in Breast Cancer
by: Claudia Cava, et al.
Published: (2020-10-01)